134 related articles for article (PubMed ID: 38868903)
21. Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes.
Estrella MY; Daniel NR; Armando ED; Cristian PM; Aarón VJ; Paul SJ; David GV; Cristian MO; de Lourdes RM; Lola EM; Alberto AG; Osbaldo RA; Rodolfo GM
Sci Rep; 2024 Apr; 14(1):9678. PubMed ID: 38678119
[TBL] [Abstract][Full Text] [Related]
22. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome.
He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X
Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952
[TBL] [Abstract][Full Text] [Related]
23. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
[TBL] [Abstract][Full Text] [Related]
24. Progressive Shifts in the Gut Microbiome Reflect Prediabetes and Diabetes Development in a Treatment-Naive Mexican Cohort.
Diener C; Reyes-Escogido ML; Jimenez-Ceja LM; Matus M; Gomez-Navarro CM; Chu ND; Zhong V; Tejero ME; Alm E; Resendis-Antonio O; Guardado-Mendoza R
Front Endocrinol (Lausanne); 2020; 11():602326. PubMed ID: 33488518
[TBL] [Abstract][Full Text] [Related]
25. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
Brunkwall L; Orho-Melander M
Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
[TBL] [Abstract][Full Text] [Related]
26. Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.
Rosell-Díaz M; Petit-Gay A; Molas-Prat C; Gallardo-Nuell L; Ramió-Torrentà L; Garre-Olmo J; Pérez-Brocal V; Moya A; Jové M; Pamplona R; Puig J; Ramos R; Bäckhed F; Mayneris-Perxachs J; Fernández-Real JM
Metabolism; 2024 Jun; 157():155941. PubMed ID: 38871078
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota compositions and metabolic functions in type 2 diabetes differ with glycemic durability to metformin monotherapy.
Hung WW; Peng P; Tsai YC; Jhou PS; Chang CC; Hsieh CC; Su YC; Dai CY; Hung WC
Diabetes Res Clin Pract; 2021 Apr; 174():108731. PubMed ID: 33676995
[TBL] [Abstract][Full Text] [Related]
28. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
29. The Gut Microbiome, Metformin, and Aging.
Induri SNR; Kansara P; Thomas SC; Xu F; Saxena D; Li X
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():85-108. PubMed ID: 34449247
[TBL] [Abstract][Full Text] [Related]
30. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Wu H; Esteve E; Tremaroli V; Khan MT; Caesar R; Mannerås-Holm L; Ståhlman M; Olsson LM; Serino M; Planas-Fèlix M; Xifra G; Mercader JM; Torrents D; Burcelin R; Ricart W; Perkins R; Fernàndez-Real JM; Bäckhed F
Nat Med; 2017 Jul; 23(7):850-858. PubMed ID: 28530702
[TBL] [Abstract][Full Text] [Related]
31. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.
Cao TTB; Wu KC; Hsu JL; Chang CS; Chou C; Lin CY; Liao YM; Lin PC; Yang LY; Lin HW
Front Endocrinol (Lausanne); 2020; 11():573891. PubMed ID: 33071980
[No Abstract] [Full Text] [Related]
32. Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.
Mardinoglu A; Boren J; Smith U
Cell Metab; 2016 Jan; 23(1):10-2. PubMed ID: 26771114
[TBL] [Abstract][Full Text] [Related]
33. Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans.
Doumatey AP; Adeyemo A; Zhou J; Lei L; Adebamowo SN; Adebamowo C; Rotimi CN
Front Cell Infect Microbiol; 2020; 10():63. PubMed ID: 32158702
[TBL] [Abstract][Full Text] [Related]
34. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C
Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106
[TBL] [Abstract][Full Text] [Related]
35. Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology.
Gao K; Yang R; Zhang J; Wang Z; Jia C; Zhang F; Li S; Wang J; Murtaza G; Xie H; Zhao H; Wang W; Chen J
Pharmacol Res; 2018 Apr; 130():93-109. PubMed ID: 29391233
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients.
Díaz-Perdigones CM; Muñoz-Garach A; Álvarez-Bermúdez MD; Moreno-Indias I; Tinahones FJ
Biomed Pharmacother; 2022 Jan; 145():112448. PubMed ID: 34844104
[TBL] [Abstract][Full Text] [Related]
37. Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study.
Lim S; Sohn M; Florez JC; Nauck MA; Ahn J
Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615904
[TBL] [Abstract][Full Text] [Related]
38. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
39. Hypoglycemic and Hypolipidemic Mechanism of Tea Polysaccharides on Type 2 Diabetic Rats via Gut Microbiota and Metabolism Alteration.
Li H; Fang Q; Nie Q; Hu J; Yang C; Huang T; Li H; Nie S
J Agric Food Chem; 2020 Sep; 68(37):10015-10028. PubMed ID: 32811143
[TBL] [Abstract][Full Text] [Related]
40. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.
Zhang W; Xu JH; Yu T; Chen QK
Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
